HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosanna Squitti Selected Research

Dianisidine

8/2017Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II).
10/2014Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosanna Squitti Research Topics

Disease

66Alzheimer Disease (Alzheimer's Disease)
03/2022 - 08/2002
17Cognitive Dysfunction
01/2021 - 05/2004
11Dementia (Dementias)
01/2022 - 12/2003
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 10/2009
9Hepatolenticular Degeneration (Wilson's Disease)
01/2021 - 01/2011
4Stroke (Strokes)
01/2018 - 02/2009
4Atrophy
01/2017 - 12/2010
3COVID-19
02/2022 - 01/2021
3Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2022 - 01/2018
3Inflammation (Inflammations)
07/2020 - 01/2012
3Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
02/2013 - 05/2004
2Nervous System Diseases (Neurological Disorders)
01/2022 - 11/2010
2Macular Degeneration (Age-Related Maculopathy)
01/2021 - 01/2019
2Retinal Diseases
01/2021 - 01/2019
2Glucose Intolerance
07/2020 - 01/2019
2Schizophrenia (Dementia Praecox)
07/2020 - 12/2006
2Hepatic Encephalopathy
12/2015 - 10/2014
2Liver Diseases (Liver Disease)
08/2012 - 10/2009
2Amyloid Plaque
01/2012 - 11/2009
1Cardiovascular Diseases (Cardiovascular Disease)
03/2022
1Amyloidosis
01/2022
1Neoplasms (Cancer)
01/2022
1Frontotemporal Dementia (Semantic Dementia)
01/2022
1Weight Loss (Weight Reduction)
01/2021
1Pain (Aches)
01/2021
1Neuroinflammatory Diseases
01/2021
1Blindness (Hysterical Blindness)
01/2021
1Neurodevelopmental Disorders
07/2020
1Epilepsy (Aura)
07/2020
1Autistic Disorder (Autism)
07/2020
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2020
1Chronic Disease (Chronic Diseases)
12/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2019
1Relapsing-Remitting Multiple Sclerosis
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Prediabetic State (Prediabetes)
01/2019
1Prodromal Symptoms
01/2018
1Brain Diseases (Brain Disorder)
01/2018
1Ischemic Stroke
01/2018
1Neuralgia (Stump Neuralgia)
12/2017
1Fibrosis (Cirrhosis)
12/2015

Drug/Important Bio-Agent (IBA)

63CopperIBA
03/2022 - 08/2002
27Ceruloplasmin (Ferroxidase)IBA
01/2021 - 02/2007
12IronIBA
07/2020 - 02/2009
9ZincIBA
02/2022 - 08/2002
8Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2012
8AntioxidantsIBA
08/2021 - 12/2006
8Transferrin (beta 2 Transferrin)IBA
01/2020 - 02/2009
7MetalsIBA
01/2018 - 10/2009
6Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2008
5Ferritins (Ferritin)IBA
07/2020 - 04/2013
4Amyloid (Amyloid Fibrils)IBA
01/2021 - 01/2013
4PeroxidesIBA
01/2018 - 05/2004
3ApolipoproteinsIBA
02/2013 - 02/2006
2Pharmaceutical PreparationsIBA
01/2022 - 01/2021
2tau Proteins (tau Protein)IBA
01/2021 - 01/2017
2Trace Elements (Biometals)IBA
07/2020 - 02/2013
2ManganeseIBA
07/2020 - 10/2009
2DianisidineIBA
08/2017 - 10/2014
2Apolipoprotein E4IBA
01/2017 - 04/2014
2Cholinesterase Inhibitors (Anticholinesterases)IBA
06/2013 - 01/2012
2Apolipoproteins E (ApoE)IBA
02/2013 - 02/2013
2Amyloid beta-PeptidesIBA
01/2012 - 11/2009
2Superoxide DismutaseIBA
12/2006 - 08/2002
2Presenilin-2IBA
04/2005 - 12/2003
1MicroRNAs (MicroRNA)IBA
03/2022
1Hemostatics (Antihemorrhagics)IBA
02/2022
1Complement System Proteins (Complement)IBA
01/2022
1RadiopharmaceuticalsIBA
01/2022
1Free RadicalsIBA
01/2022
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2022
1MicronutrientsIBA
08/2021
1Antiviral Agents (Antivirals)IBA
08/2021
1Prion ProteinsIBA
01/2021
1remdesivirIBA
01/2021
1Nerve Growth Factors (Neurotrophins)IBA
01/2021
1SynucleinsIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021
1FlavonoidsIBA
01/2021
1QuercetinIBA
01/2021
1Fenofibrate (CiL)FDA LinkGeneric
01/2021
1Cholinergic Agents (Cholinergics)IBA
01/2021
1LopinavirFDA Link
01/2021
1Nerve Growth Factor (NGF)IBA
01/2021
1CholesterolIBA
01/2021
1SeleniumIBA
07/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2020
1Antipsychotic Agents (Antipsychotics)IBA
07/2020
1CatecholaminesIBA
07/2020
1Methylphenidate (Ritalin)FDA LinkGeneric
07/2020
1CobaltIBA
07/2020
1gamma-Aminobutyric Acid (GABA)IBA
01/2020
1Genetic Markers (Genetic Marker)IBA
01/2020
1Insulin (Novolin)FDA Link
12/2019
1Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2017
1IonsIBA
01/2017
1Familial apoceruloplasmin deficiencyIBA
06/2015

Therapy/Procedure

5Therapeutics
01/2022 - 11/2009
1Drug Therapy (Chemotherapy)
01/2022